Cost-per-responder analysis for eltrombopag and rituximab in the treatment of primary immune thrombocytopenia in Spain

by Eduardo Anguita, Francisco Javier Parrondo García, José Ramón González-Porras
Published 2020-11-01

Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs

by Francisco Javier Parrondo-García, José Manuel Martínez-Sesmero, Javier De Castro-Carpeño, Araceli López-de las Heras, Alonso Fernández-Nistal
Published 2021-03-01

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain

by Santiago Moreno Guillen, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefenhain, David Lopez Sanchez-Cambronero, Francisco Javier Parrondo Garcia
Published 2017-09-01